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Variation in Expression of Na K ATPase a and /3 Subunit mRNAs 
in Rat Tissues and Nervous System Cell Lines 
Susan Lynn Garetz 
1989 
The expression of the Na+K+ATPase a and subunits has been examined in 
rat tissues at several stages of development and in a number of cell 
lines derived from components of the rat central nervous system. 
Significant differences in expression were seen in the tissue and 
developmental specificity of the genes encoding three a subunit 
isoforms. The transcript encoding the al isoform was seen in all of the 
tissue types examined whereas the transcripts encoding the a2 and q3 
isoform mRNAs were expressed predominantly in brain. A varied pattern 
of mRNA expression was also seen for the /3 subunit which did not 
correspond to the patterns seen with any of the a subunits. Transcripts 
of each of the three a subunit isoforms were also expressed in all of 
the cell lines derived from the nervous system. The /3 subunit was 
expressed, however, only in a rat pheochromocytoma cell line. These 
patterns of expression suggest that the various isoforms of the 
Na K ATPase may perform specialized functions in diverse tissues and 
during various stages of development, and that their regulation is 
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The Na+, K+-activated adenosine triphosphate phosphatase 
(Na+K+ATPase) is an integral membrane protein found in most animal cells 
that uses energy derived from ATP hydrolysis to transport Na+ and 
K+across the cell membrane against their concentration gradients. The 
enzyme is composed of two polypeptides. The a subunit is a polypeptide 
of M^-100,000 and contains the site of ATP hydrolysis.’*' It is thus 
responsible for the enzyme's catalytic activity. In addition, the a 
subunit contains the binding site for the cardiac glycosides.'*' The 
smaller /3 subunit is a glycosylated protein of M^-55,000 whose function 
is currently unknown.^ It is commonly assumed that the active form of 
the enzyme in cell membranes is some multiple of an ct^/39 tetramer but 
the exact subunit stoichiometry remains in dispute. 
For a number of years investigators have published data consistent 
with the existence of more than one form of the Na+K+ATPase enzyme. It 
has been shown that astrocytes possess a low affinity K+ uptake not seen 
2 
in neurons. These glial cells also display marked osmotic swelling 
2 
when treated with ouabain. Tobin showed that the dissociation of 
ouabain from Na+K+ATPase differed within a given species and that in 
guinea pig brain the plotted dissociation curve was nonlinear, 
suggesting that forms of the enzyme with different functional properties 
3 
could exist in the same animal. Erdmann and Schoner also reported 
+ + 4 
different affinities for ouabain by the Na K ATPase enzyme. The 
advent of techniques that allowed the preparation of relatively pure 

2 
fractions of neurons and glia enabled Henn et al. to demonstrate that 
glial cell ATPase was always between two and four times more active than 
the neuronal enzyme as well as markedly more sensitive to variations in 
K+ ion concentration. 
Sweadner provided the first concrete evidence for the existence of 
multiple forms of the Na+K+ATPase by isolating two forms of the enzyme 
from rat brain.^ These two distinct proteins could be resolved by gel 
electrophoresis in sodium dodecyl sulfate (SDS). The two proteins also 
displayed differences in their sensitivity to trypsin digestion, in 
reactivity of sulfhydryl groups and in affinity for the cardiac 
glycoside strophanthidin, an aglycone analog of ouabain. Sweadner found 
that the isozyme of Mr 100,000, which she designated a+, localized only 
to the plasma membrane of myelinated axons. Conversely, the smaller 
isoform, designated a, was seen in all other tissue types examined as 
well as in non neuronal (glial) central nervous system and superior 
cervical ganglion cells.^ 
Subsequent research has provided more detailed information 
concerning the functional properties of these two a subunits. The a and 
a+ isoforms have been shown to differ in their interactions with 
7 8 9 
phospholipids, regulation by thyroid hormone and insulin, and 
inhibition by pyrithiamin.^ The two isozymes of the a subunit have 
also been shown to contain distinct antigenic determinants.^ 
Recent studies have shown that the a subunit isoforms are more 
prevalent than originally reported. Matsuda and his colleagues found 
two forms of Na+K+ATPase a subunit in canine cardiac preparations that 

3 
could be separated by SDS electrophoresis and differed in their 
inhibition by pyrithiamin.^ Recent work by Maixant et al., also 
provided evidence of a second form of the a subunit in dog heart using 
immunological techniques. The two a subunit isoforms were both shown to 
be active in dog heart. The isoforms differed in their affinity for 
12 
ouabain and digitoxigenin by a factor of 150. Similar findings of 
two molecular forms of Na+K+ATPase and two classes of ouabain receptors 
13 
have also recently been reported in ferret heart. Interestingly, 
Matsuda failed to detect a second isoform in cardiac samples from a 
number of other animals including guinea pig, rat, mouse, rabbit and 
cow.^ McDonough and Schmitt were also unable to find a second form of 
14 
the enzyme in guinea pig heart. These results were especially 
intriguing in the face of mounting evidence for the existence of two 
populations of ouabain receptors in preparations from cardiac muscle 
from several species including rat, dog, and guinea pig.^^^^ 
Isoforms of the a subunit of the Na+K+ATPase have also been found 
in tissues other than brain and heart. Lytton described an insulin 
sensitive isoform in rat adipocytes and skeletal muscle similar in size 
9 
and ouabain sensitivity to the a+ form described by Sweadner . The 
existence of a and a+ isoforms has also been reported in distinct 
19 
populations of mammalian ciliary cells, in retina, and in optic 
20 
nerve. 
In addition to differences in functional properties and tissue 
localization, experimental data suggests that the Na+K+ATPase varies in 
location, prevalence, and function during development. Details of the 

4 
variation remain controversial. Abdel-Latiff and Abood reported a more 
than six fold increase in Na+K+ATPase activity in nerve ending fractions 
21 
from pre-natal to ten day old rats. Conversely, Samson et al. found 
an absence of enzyme activity in the brains of newborn rats and then a 
22 
rapid increase in activity between ten days and three weeks. Cote 
reported detecting Na+K+ATPase activity in rat fetus as early as sixteen 
23 
days of gestation. Schmitt and McDonough found a ten-fold increase 
between the eighteenth day of gestation and twenty day old rat neonates 
24 
and then a 1.8-fold increase between those neonates and adult rats. 
It has also been observed that several characteristics of the 
Na+K+ATPase differ between fetal and adult rat brains including specific 
2526 27 
activity ' and temperature dependence. Wilson described a number 
of other differences in Na+K+ATPase activity between these two age 
groups including disparate apparent values of activation by K+ and 
ATP hydrolysis, activation by phosphatidyl choline, and relative 
2 8 
inhibition by a fixed concentration of ouabain. Recently, Schmitt and 
McDonough have used immunological techniques to detect a marked increase 
in the abundance of the a and a+ subunits in rat brain during pre- and 
neo-natal development which appears to be regulated by thyroid 
hormone.^ 
Developmental differences in a subunit expression have also been 
noted in other tissues. Newborn rat myocytes contain high and low 
affinity digitalis receptors that are not present in preparations from 
29 30 
adult rat. ' Changes in relative amounts of two molecular forms of a 

5 
subunit protein during development have also been described in brine 
shrimp.^ 
Recently, cDNAs have been isolated for the two Na+K+ATPase a 
32 33 
subunit isoforms and their primary sequence has been deduced. ' 
Surprisingly, a cDNA clone corresponding to a third rat Na+K+ATPase 
subunit, designated variously as alll and , has now also been isolated 
32 33 
by several groups using cDNA cloning techniques ' . The protein 
encoded by this gene has not yet been detected but the corresponding 
34 
mRNA has been identified in rat brain, stomach and lung 
In contrast to the a subunit, only one form of the /3 subunit of the 
Na+K+ATPase has been isolated to date. The cDNA sequence has now also 
been established for the rat, torpedo, human, and dog (3 subunit genes. 
Their deduced amino acid sequences show a high degree of 
35 36 37 
homology. ' ' In rat the /3 subunit gene encodes four distinct mRNA 
species which are expressed in a tissue specific fashion. None of these 
species .however, were detected by Northern blot analysis in 
38 
preparations from rat liver. Hubert et al. were also unable to 
detect the known form of this protein in rat hepatocytes using 
39 + + 
immunological techniques. The absence of the Na K ATPase /3 subunit 
and expression of its corresponding mRNA in a tissue known to possess 
Na+K+ATPAse activity raises the possibility that other isoforms of the /3 
subunit exist. 
Recent work has shown that the three isoforms of the a subunit 
Na+K+ATPase are encoded by multiple genes which are located on separate 
40 
chromosomes in the mouse. The a or al subunit gene (Atpa-1) is 

6 
located on chromosome three, the a2 or alll gene (Atpa-2) has been 
mapped to chromosome seven, and the gene for the a3 or a+ isoform (Atpa- 
3) is present on chromosome one. The subunit gene (Atpb) is also 
located on chromosome one, but it is not tightly linked to the a subunit 
33 
gene on that chromosome. This information raises a number of 
questions regarding the control mechanisms used to generate the 
diversity seen in the enzyme's functional properties and activity level 
in various tissues and developmental periods. 
Experimental evidence suggests that synthesis of the Na+K+ATPase a 
and /3 subunits is coordinately regulated. Using an immunological assay, 
Tamkum and Fambrough detected concurrent biosynthesis of a and /3 
41 
subunits in chick sensory neurons. Similar findings have been 
reported in toad bladder tissue after stimulation with aldosterone. 
42 
44 
Other studies have shown that in a variety of target tissues exposure to 
+ + 43 
thyroid hormone results in an increase in Na K ATPase activity. A 
study of kidney tissue from rats infused with triiodothyronine, however, 
showed an increase in synthesis of the a subunit protein with no 
corresponding increase in the protein identified as the /3 subunit. 
It has also been reported that expression of the mRNAs encoding the 
a and /3 subunits is coordinately controlled under certain conditions. 
After stimulation with aldosterone of a cell line derived from Xenopus 
+ + 
kidney the induction of Na K ATPase activity was shown to be mediated by 
a two- to four-fold increased accumulation of both a and /3 subunit 
45 
mRNAs. Girardet et al. showed that in toad bladder cells either 
oxytocin or aldosterone administered alone increased the relative rate 

7 
of synthesis of the a and (5 subunits of the Na+K+ATPase. When both 
hormones were applied simultaneously a markedly increased effect was 
seen at the physiologic level. In contrast, no such synergistic effect 
46 
was evident in the rate of mRNA synthesis. 
Other lines of investigation have produced similar discrepancies. 
Bowen and McDonough found that in cultured canine kidney cells grown in 
a low concentration of K+, an increase in Na+K+ATPase activity could be 
attributed to a rapid and coordinate increase in a and /3 subunit mRNA 
which was followed by an increase in a and /3 subunit proteins as 
47 
measured by immunoprecipitation. In contrast, data obtained from 
experiments done on cultured chicken skeletal muscle by Wolitzky and 
Fambrough indicated that up regulation of Na+K+ATPase occurred by a 
combination of early stimulation of a and /3 subunit biosynthesis 
48 
followed by a decrease in the enzyme's turnover rate. 
In a cell line derived from HeLa cells by mutagenesis and step-wise 
selection in ouabain, the development of a ouabain resistant phenotype 
has been demonstrated to be accompanied by a marked increase in 
expression of both the a and /3 subunits relative to the parent cell 
49 
line. Other studies, however, have attributed the ouabain induced 
increase in surface density of the Na+K+ATPase enzyme to a change in the 
_ . 50 
rate constant for its turnover. 
In order to further investigate the tissue and developmental stage 
variation of the three a subunit isoforms and the /3 subunit of the 
Na+K+ATPase enzyme and to study the regulation of its biosynthesis I 
have examined the expression of the corresponding mRNAs in rat brain, 

- 8 - 
heart, liver and kidney at three representative stages of development. I 
have also studied the expression of the a and f3 subunit mRNAs in cell 
lines derived from both neuronal and glial elements of the rat central 
nervous system. Finally, I compared the levels of mRNA expression in 
the rat PC12 cell line grown with and without the presence of a nerve 
growth factor. PC12 cells are of pheochromocytoma origin and 
differentiate into cells resembling sympathetic neurons when induced by 
51 
NGF. 
Substantial differences in expression of the mRNAs encoding the 
Na+K+ ATPase A and B isoforms were seen both in the various tissues 
examined and in the same tissues at different developmental stages. 
Moreover, these patterns were distinct and separate for the three a and 
the (3 subunit genes. Each of the three a isoforms was also expressed in 
all of the rat central nervous system (CNS) and pheochromocytoma cell 
lines. The (1 subunit mRNA was expressed only in the pheochromocytoma 
cells. These distinct patterns of expression of the mRNAs corresponding 
to the Na+K+ATPase subunits raises the possibility that the different 
members of this multi-gene family may have specialized functions and 
suggests that their regulation may be in part controlled by factors 
other than the level of RNA expression. 

9 
2. MATERIALS AND METHODS 
Cell lines and Culture Conditions 
Rat central nervous system (CNS) cell lines B35, B50, B60, and B103 
(neuronal) and B15 and B82 (glial) were generously provided by Dr. David 
Schubert of the Salk Institute. The cells were maintained in Dulbecco's 
modified Eagle's medium supplemented with 15% fetal calf serum. 
PC12 cells were kindly donated by the lab of Dr. Ed Hawrot of Yale 
Medical School. These cells were maintained in Dulbecco's modified 
Eagle's medium supplemented with 10% fetal calf serum and 5% horse 
serum. A group of these cells was also grown for 9 days in 20 ng/ml 
nerve growth factor (Calbiochem). 
Preparation of Total Cellular RNA 
RNA was isolated from the rat CNS and PC12 cell lines and from 
fresh brain, heart, liver, and kidney of fetal (18 day), newborn (two 
week), and adult rats using the guanidinium isothiocyanate method 
52 
described by Chirgwin et al.. In brief, freshly removed tissue was 
placed in 25 mis of guanidinium isothiocyanate stock, (4 M guanidinium 
isothiocyanate, 0.5% N lauroyl sarcosine, 25 mM sodium citrate, 0.1 M 
/3-mercaptoethanol, and 0.1% Sigma 30% antifoam A), and immediately 
homogenized for one minute. The homogenate was then centrifuged for ten 
minutes at 8000 rpm. The supernatant was mixed with 0.6 ml of 1.0 M 
acetic acid and 18 mis of absolute ethanol and allowed to precipitate 
overnight at -20° C. This solution was then centrifuged at 6000 rpm for 

10 
ten minutes at -20° C. The pellet was resuspended in 15 mis of 
guanidine hydrochloride stock solution, (7.5 M guanidine hydrochloride, 
0.025 vol. 1.0 M sodium citrate, and 5 mM dithiothreitol). 0.4 ml 1.0 M 
acetic acid and 8 mis ethanol was added to reprecipitate and the mixture 
was kept at -20° C and centrifuged as above. A final reprecipitation 
was performed with a further halving of all volumes and the resulting 
solution was centrifuged at 6000 rpm for 5 minutes. The pellets were 
then rinsed in ethanol and recentrifuged at 6000 rpm. Finally the RNA 
was dissolved in sterile water and stored at -70° C. 
Total cellular RNA from cultured cells was prepared using the same 
procedure except that the guanidinium isothiocyanate solution was 
applied to monolayers of each of the cell types and allowed to stand for 
five minutes before the mixture was homogenized. 
RNA Blot Hybridization 
Total cellular RNA (20 fig) was denatured by heating at 65° C for 
ten minutes in 50% (vol/vol) formamide and was fractionated by 
53 
electrophoresis through a 1% agarose formaldehyde gel. The RNA was 
then transferred to reusable hybridization membranes (Zetabind, AMF 
Cuno). 
The RNA blots were prehybridized for 24 hours at 42° C. The 
prehybridization buffer consisted of 50% (vol/vol) formamide, 5x sodium 
chloride, 50 mM sodium phosphate, sonicated, denatured salmon sperm DNA 
at 250 ng/ml, and 0.02% each bovine serum albumin, ficoll, and 
54 55 
polyvinylpyrrolidone. ' The hybridization buffer contained four 

11 
parts prehybridization buffer and one part 50% (wt/vol) dextran sulfate 
as well as 100 /ig/ml each of single stranded poly(A) , poly(I) and 
poly(C) ribonucleotides at 100/ig/ml each (Boehringer-Mannheim) . 
Radiolabeled DNA probes were synthesized using the Klenow fragment of 
DNA polymerase 1 with random hexanucleotides (Boehringer-Mannheim) and 
[a-32p] dCTP.56 
The RNA blots were hybridized with 10^ cpm (<50 ng) of the various 
hybridization probes for 24 hours and were then washed to a final 
stringency of 15 mM sodium chloride, 1.5 mM sodium citrate, and 0.1% 
SDS at 55° C and exposed to Kodak XRP film at -80° C with an 
intensifying screen. For reprobing, blots were washed twice for 15 
minutes in 15 mM sodium chloride, 1.5 mM sodium citrate, 1.3 mM KH^PO^, 
100/jM EDTA and 0.1% SDS at 95° C. 
cDNA Probes 
A map of the rat Na+K+ATPase a and /3 subunit cDNA clones is shown 
in Figure 1. Each of the RNA blots was probed with the following coding 
regions from the three Na+K+ATPase a subunit isoforms: 
1. A 3.2 kilobase pair (kbp) rat cDNA containing the entire 
coding region from the a (al) subunit gene (Atpa-1). 
2. A 1.8 kbp Eco RI fragment of the rat cDNA encoding the amino 
terminal portion of the alll (a3) subunit gene (Atpa-2). 





In addition, each blot was also probed with a 1.2 kbp cDNA 
containing the entire coding region of the rat Na+K+ATPase /3 subunit 
gene (Atpb). 
As a control each blot also was hybridized with a human gamma actin 
cDNA probe (pHFy A) kindly supplied by Dr. Larry Kedes of Stanford 
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Figure 1. Map of rat Na+K+ATPase a and /3 subunit cDNA clones. 
Solid lines represent the open reading frame and hatched boxes represent 
the untranslated regions. Dotted lines represent the fragement of a 
clone that was used as a probe. Restriction sites: B, BamHI; E, 
BstEII: G, Bgll; H, ffindlll; K, Kpn I; M, MstII; N Nco I; P, Pst I; R, 




Tissue and Developmental Stage Specific Expression of Na K ATPase a 
Subunit mRNAs 
Expression of the mRNAs encoding the three known isoforms of the 
Na+K+ATPase was examined by sequentially hybridizing cDNA probes 
specific for each of the isoforms to a Northern blot containing total 
cellular RNA from rat brain, heart, kidney and liver at three different 
stages of development. Previous experiments using these probes have 
shown that virtually no cross hybridization occurs in Southern genomic 
33 
blots hybridized under the same conditions. The results of these 
Northern blots are shown in Figure 2. 
The al subunit cDNA probe hybridized to an approximately 4.5 kb 
RNA species as shown in the al panel. In adult rat, transcripts of the 
Atpa-1 gene were most prevalent in kidney. Fewer transcripts were 
apparent in adult heart and brain. Even fewer transcripts were 
expressed in the RNA from adult liver tissue. Atpa-1 mRNA was also 
abundant in newborn (two week) brain, heart, and kidney as well as fetal 
(18 day) heart and kidney. It was less abundant in fetal brain and 
liver and newborn liver. 
A different pattern of expression was seen for the Atpa-2 gene 
which encodes the a2 or alll subunit although it also hybridized to an 
mRNA of approximately 4.5 kb in length. As shown in the q2 panel of 
Figure 2, this mRNA was most prevalent in newborn and adult brain and in 
newborn liver. Moderate levels of Atpa-2 mRNA were detected in adult 

15 
kidney and liver and newborn kidney. In heart tissue at all the 
developmental stages examined and in fetal kidney a very low level of 
expression was seen. No transcripts of the Atpa-2 gene were visible in 
fetal brain or liver. 
The results of hybridization of the Northern blot with the cDNA 
which encodes the a3 or a+ subunit is also shown in Figure 2 (panel a3). 
The Atpa-3 gene hybridizes to three distinct mRNA species of 
approximately 6.0, 4.5, and 4.0 kb in length. These multiple mRNA 
species are consistent with the published sequence data for the a+ gene 
32 
which contains three possible sites for polyadenylation. Transcripts 
of the 6.0 kb mRNA were most abundant in newborn and adult brain. They 
were less abundant in fetal heart and kidney, in newborn kidney and 
liver, and in adult heart and liver. The 4.5 kb mRNA was expressed 
predominately in two week brain. Lower levels of expression of this 
gene were observed in fetal heart, newborn heart, kidney and liver, and 
in adult rat kidney and liver. The 4.0 kb mRNA species had the most 
restricted pattern of expression. It was detected only in fetal kidney 
and in adult brain and heart. 
The same Northern blot showed bands of approximately equal 
intensity when probed with actin cDNA. The differences in intensity of 
hybridization seen with the various a subunit probes are therefore 
probably a reflection of variation in level of mRNA expression. These 
results demonstrate that the three known Na+K+ATPase a subunit isoform 




Tissue and Developmental Stage Specific Expression of the Na+K+ATPase B 
Subunit mRNA 
The results of hybridizing the Northern blot of rat tissues with a 
probe of the Na+K+ATPase /3 subunit cDNA are shown in the panel of 
Figure 2. The Atpb gene encodes four distinct mRNA species which range 
from approximately 3.0 to 2.0 kb in length. Transcripts of the mRNA 
were most abundant in adult brain and newborn liver. A lower level of 
expression was seen in fetal and adult kidney and the lowest level was 
observed in newborn brain and kidney and in heart tissue at all three 
developmental stages. No hybridization was detected to the RNA from 
fetal brain and liver or adult liver. 
The same blot probed with actin cDNA revealed a single mRNA species 
that hybridized to all lanes with approximately equal intensity (Figure 
2, actin panel). These results demonstrate that the Na+K+ATPase /3 
subunit gene Atpb is also expressed in a tissue and developmental 
specific fashion and that its pattern of expression differs from that 
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Expression of the mRNAs Encoding the Na K ATPase a and 6 Subunits in 
Cell Lines Derived from Components of the Rat Nervous System 
The various isoforms of the Na+K+ATPase enzyme may be localized in 
.... . . . . , .. 6,19,20 
specific cell types or regions within the central nervous system. 
It has also been shown that superior cervical ganglion cells of the 
peripheral nervous system, in contrast to neuronal cells of the CNS, do 
not contain detectable levels of the a+ form of the a subunit. 
Several lines of experimentation have shown that cultured cell 
lines derived from neural and glial components of the CNS may serve as 
reasonable models for the ion transport properties of their tissue 
57 58 
counterparts. ' It has also been established that the PC12 cell 
line, which is derived from rat adrenal pheochromocytoma cells of neural 
crest origin, develops the morphology and many of the characteristics of 
sympathetic neurons when it is grown in the presence of nerve growth 
51 
factor. To ascertain whether variation exists in pattern of mRNA 
expression in specific cell types within the nervous system, a Northern 
blot containing total cellular RNA from four cell lines of neuronal 
derivation (B35, B50, B60 and B103) and two cell lines of glial origin 
59 
(B15 and B82) as well as RNA from PC12 cells cultured with and without 
nerve growth factor was hybridized with cDNA probes of Na+K+ATPase a and 
P subunits. The results are shown in Figure 3. 
Transcripts of the Atpa-1 and Atpa-2 genes were expressed in all of 
the cell lines examined (panels al and a2). The Atpa-3 gene was also 
expressed in each of the cell lines as shown in panel a3. The 4.5 kb 
mRNA species of this gene was detected in the B15, B35, B60, B82, B103 

18 
and PC12 cells. In contrast, the 6.0 and 4.5 kb mRNA species of this a 
subunit isoform were apparent only in RNA from the B50 cells. 
A markedly different set of data was obtained when the same 
Northern blot was hybridized with a cDNA probe coding for the 
Na+K+ATPase f) subunit. Transcripts of the Atpb gene were seen only in 
PC12 cells (Figure 3, panel /3) . 
As shown in the actin panel of Figure 3, an actin cDNA probe 
applied to this Northern blot produced hybridization of approximately 
equal intensity in the lanes corresponding to each of the cell lines. 
The inability to detect /J subunit mRNA transcripts in the majority of 
these cell lines is thus probably caused by either a low level or 
complete lack of expression of the /3 subunit gene in those cells instead 
of RNA degradation or a flaw in the hybridization technique used. 
Of note is that the PC12 cell line showed striking differences in 
expression of the a and f3 subunit mRNAs when grown in the presence of 
NGF. The al cDNA probe produced hybredization of approximately equal 
intensity for the PC12 cells grown with or without NGF. The intensity 
of the a2 cDNA probe, however, markedly decreased in the lane 
corresponding to cells grown with NGF. A down-regulation of /3 subunit 
mRNA was also seen in the NGF-induced PC12 cells. In contrast, a much 
higher intensity of hybridization was apparent with the mRNA from the 
NGF-induced PC12 cells when the a3 probe was used. 
The patterns of expression of the Na+K+ATPase a and (3 subunits seen 
in these cell lines of nervous system origin indicate that expression of 
the three a subunits is fairly widespread within the components of that 

19 
tissue. In contrast, expression of the /? subunit gene is much more 
circumscribed. Moreover, the differences in expression of the a and /3 
subunit mRNAs between PC12 cells grown in standard media and those 
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Figure 2. Expression of the Na+K+ATPase a and subunit genes in 
rat tissues. Total cellular RNA (20 /xg) was prepared from fetal (18 
day), two week old, and adult rat tissues and sequentially hybridized 
with the cDNA probes indicated on the right. The positions of the 28S 
and 18S markers are indicated on the left. The arrowheads on the right 
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Figure 3. Expression of the Na+K+ATPase in rat cell lines. Total 
cellular RNA (20 /ig) prepared from the rat CNS cell lines described in 
the text and from PC12 cells growth in the absence (-NGF) or presence 
(+NGF) of nerve growth factor were sequentially hybridized with the cDNA 
probes indicated on the right. The positions of the 28S and 18S 
markers are indicated on the left. The arrowheads on the right denote 
the positions of the a and /3 subunit mRNA sequences. 

4. DISCUSSION 
For a number of years investigators have produced data showing that 
variation exists in the activity level and character of the Na+K+ATPase 
enzyme both in various tissues of the same species and in the same 
tissue at different developmental stages. There are, however, a number 
of discrepancies in this body of data. Studies of this ubiquitous 
enzyme have indicated that the biosynthesis of its a and /3 subunits is 
coordinately regulated and that changes in the rate of subunit 
biosynthesis is the major control mechanism of enzyme activity. Data 
also exist that contradict this hypothesis. The discovery of various 
isoforms of the Na+K+ATPase enzyme and the molecular cloning of the 
cDNAs encoding them have provided the means for a more in depth 
investigation of both the molecular correlates of the tissue and 
developmental stage specific variation observed and of the control 
mechanisms regulating this diversity. 
The discovery that the a subunits of the Na+K+ATPase exist as a 
multigene family with at least three members provides a possible 
explanation for many of these discrepancies in data concerning the 
functional properties and activity level of the enzyme. Many of the 
assays traditionally used to ascertain the presence of the Na+K+ATPase 
enzyme employ characteristics such as cardiac glycoside binding or 
presence of certain antigenic determinants that have been shown to 
differ in at least two of the known isoforms of the a subunit. It is 
therefore possible that previous studies may have relied on assays that 

23 
were preferentially sensitive to a particular isoform and for that 
reason produced spurious or contradictory results. My experimental data 
indicates that the /3 and various a subunit mRNAs each display distinct 
pattern of expression in the tissue types and developmental periods 
examined. The isolation of new members of this multigene family and the 
proteins encoded by them should enable many of the existing ambiguities 
concerning distribution of the enzyme to be resolved. 
The discovery that the Na+K+ATPase enzyme exists in a number of 
forms that differ radically in their distribution raises several other 
issues that may prove much more difficult to address. Perhaps the most 
intriguing of these questions is that of the functional correlates to 
the observed diversity. It would seem a reasonable hypothesis that the 
various isoforms have evolved to satisfy a need for divergent functions 
of the Na+K+ATPase enzyme. 
Several lines of evidence indicate that the isoforms of the enzyme 
fulfill a variety of roles. This diversity is perhaps best illustrated 
in the nervous system. It has been demonstrated that the appearance of 
the Na+K+ATPase correlates well with the onset of electrical activity in 
60 
rat brain. In neurons, the enzyme is found in especially high 
concentrations and is responsible for maintaining the high ionic 
gradients necessary for both the generation of nerve impulses and 
61 
neurotransmitter uptake. Glial cells have been shown to contain a 
form of the Na+K+ATPase enzyme that is more sensitive to variations in 
K+ concentration than the neuronal form, a property well suited to the 
function of these cells in regulating the concentration of the K+ ion in 
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the extracellular space surrounding the neurons. ' These functional 
differences correlate well with published data that the a+ isoform of 
the Na+K+ATPase enzyme is found in myelinated axons whereas in non¬ 
neuronal cells of the CNS the al subunit is present. One potential 
problem with this assignment of specific functions to these a subunit 
isoforms in nervous system tissue is that neurons of the sympathetic 
nervous system appear to contain only the al isozyme. It has also been 
demonstrated that the al and a+ isoforms are present in distinct ciliary 
epithelial and optic nerve cell populations where their differences in 
19 20 
function are less clear. ' My results indicate that in addition to 
the a and a+ isoforms the a2 (or alll) subunit gene is also expressed 
at fairly high levels in developing and adult rat brain. More 
experiments are needed to determine whether the protein encoded by this 
gene is also present in brain tissue and what, if any, specialized 
functions it performs. 
Curiously, in the cell lines derived from neuronal and glial 
elements and in the nerve growth factor induced pheochromocytoma (PC12) 
cells expression of each of the three a subunit isoforms was observed, 
albeit at somewhat varying levels. One possible explanation is that the 
cultured cell lines had in some way de-differentiated and were therefore 
displaying properties characteristic of more pluripotent cell types. 
This is unlikely to be the case for two reasons. First, not all of the 
isoforms were detected in RNA from fetal rat brain tissue which is 
ostensibly not yet fully differentiated. Second, a more circumscribed 
pattern is seen with fi subunit expression in the same cultured cell 
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lines. Another possibility is that all of the Na+K+ATPase a subunit 
genes are transcribed in nervous system cells and then only specific 
mRNAs are translated. Another possible scenario is that multiple 
isoforms can exist in a given cell type, perhaps with specific 
subcellular localization. Data showing approximately equal synthesis of 
the al and a+ subunit isoforms in optic nerve but axonal transport of 
20 
predominantly the a+ form is consistent with such a system. This 
theory, however, is challenged by my data showing that PC12 cells up and 
down regulate subunit mRNA transcription when induced by NGF. More 
specific assays could provide useful information concerning the exact 
cellular and subcellular localization of the various Na+K+ATPase 
isozymes within the nervous system, as well as new insights into the 
relationship between localization and function in that organ system. 
Specialized functions of the Na+K+ATPase enzyme isoforms have been 
identified in other tissues as well as in the nervous system. In dog 
heart, it has been demonstrated that the a+ isoform is responsible for 
the positive inotropic effect of the cardiac glycosides whereas the al 
isoform has been implicated in the toxicity associated with those 
12 
agents. Studies in ferret heart indicate, however, that the al and a+ 
isoforms are associated with high and low affinity ouabain binding sites 
and that ouabain can interact with either of these receptors to produce 
13 
its positive inotropic effect. In rat adipocytes it has been shown 
that both the a and a+ isoform are present but only the a+ form is 
9 
sensitive to stimulation by insulin. My data showing significant 
differences in the expression of the three a subunit isoform and /3 
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subunit mRNAs in rat heart, kidney, and liver tissue support the idea 
that specialized function is related to preferential expression of 
certain isoform mRNAs. 
Experiments on the physiological characteristics of the 
Na+K+ATPase during various stages of development have shown differences 
in some tissues. Charlemagne et al. showed that in newborn rat heart 
ouabain is bound and released at a rate four to five times slower than 
in normal adult rat heart. Interestingly, a similar rate was observed 
6 3 
in myocardium that had hypertrophied in response to mechanical stress. 
Paradoxically, in my experiments heart tissue displayed the least 
variation in expression of Na+K+ATPase subunit mRNAs of any tissue 
examined. In brain tissue a similar discrepancy exists between level of 
expression and observed physiological differences in functional 
properties and activity level. Schmitt and McDonough demonstrated a ten 
fold increase in Na+K+ATPase activity between 18 day fetal rats and 
28 
those 20 days old. My data showed an approximately five to ten fold 
increase in a subunit mRNA between fetal and two week old rats. 
Expression of the /3 subunit, however, increased even more in the same 
time period. These results warrant further investigation of the 
activity levels of the Na+K+ATPase enzyme during various stages of 
maturation in different tissue types. 
My data show marked variation in mRNA expression of the 
Na+K+ATPase a and (3 subunits in various tissue types at different 
developmental stages. This diversity, as well as the known variation in 
enzyme character and activity level, cannot be explained solely by 
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levels of mRNA expression; it raises the question of what control 
mechanisms generate this tremendous diversity. Experiments have shown 
that the a and (3 subunits are coordinately synthesized and that control 
of enzyme activity is effected largely by changes in the synthesis rate 
42 46 48 
of the mRNAs encoding the subunit proteins. ' ' The discovery that 
the genes for the a subunit isoforms and the /3 subunit lie on separate 
chromosomes makes it unlikely that a common cis acting control mechanism 
is responsible. My experimental data strongly suggest that the 
diversity observed on the physiological level cannot be explained solely 
on the basis of level of gene expression and therefore support the idea 
that other factors play a contributory role in the control of 
biosynthesis of the Na+K+ATPase enzyme. Although changes in turnover 
rate constant has been implicated by several lines of 
experimentation,^my data suggest another possibility. I have shown 
that the mRNA of the known subunit is not expressed in liver or in any 
of a number of cell lines derived from glial or neuronal components of 
the central nervous system or from the sympathetic nervous system. 
These data, as well as previous work of several investigators who were 
unable to detect either the protein or the mRNA corresponding to the /3 
35 39 
subunit in liver tissue, ' support the hypothesis that either as yet 
undetected isoforms of the /3 subunit exist which differ considerably 
from the known form or that the /3 subunit is not always a necessary 
component for enzymatic activity in some tissues. This speculation is 
at variance with the established belief that the active form of the 
enzyme exists as some multiple of an a[3 dimer, but raises another 

28 
possibility for a diversity-generating control mechanism. It is 
possible that enzyme activity level and function may be determined by 
different combinations of a and [i subunit isoforms or a subunit isoforms 
functioning alone. This theory is supported by recent work of Numa and 
his colleagues showing that Xenopus oocytes injected with the 
Na+K+ATPase a and subunit mRNAs produced more a subunit polypeptides 
than oocyctes injected with the same concentration of a subunit mRNA 
. 64 
alone. 
Identification of the cDNAs encoding the Na+K+ATPase a and /3 
subunit isoforms and the isolation of their associated proteins are 
required to provide more satisfying answers to the related issues of 
function and control raised by the variability in distribution, 
functional properties, and mRNA expression of this enzyme. The 
development of systems to transfer and express the genes encoding 
Na+K+ATPase subunit isoforms in bacteria or other lower organisms, as 
well as exploitation of characteristics such as varying sensitivity to 
cardiac glycosides, should provide researchers with data needed to 
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